https://ift.tt/2IEU2UP support@endlesssupplies.biz (Endless Supplies .Biz) February 26, 2019 at 01:52AM
Tuesday, February 26, 2019
AstraZeneca's Lynparza meets main goal of late-stage cancer study
British drugmaker AstraZeneca Plc said on Tuesday its cancer drug being jointly developed with U.S.-based Merck & Co met the primary goal in a late-stage study for pancreatic cancer.
https://ift.tt/2IEU2UP support@endlesssupplies.biz (Endless Supplies .Biz) February 26, 2019 at 01:52AM
https://ift.tt/2IEU2UP support@endlesssupplies.biz (Endless Supplies .Biz) February 26, 2019 at 01:52AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment